|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006826,
umls-concept:C0013216,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0038250,
umls-concept:C0040736,
umls-concept:C0205390,
umls-concept:C0210630,
umls-concept:C0229664,
umls-concept:C0300926,
umls-concept:C0332283,
umls-concept:C0439505,
umls-concept:C2603343
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2003-1-9
|
|
pubmed:abstractText |
It is not known whether increasing the dose of filgrastim after mobilizing chemotherapy improves collection of peripheral blood progenitor cells (PBPC) and leads to faster hematopoietic engraftment after autologous transplantation.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0041-1132
|
|
pubmed:author |
pubmed-author:AndréMarcM,
pubmed-author:BaudouxEtienneE,
pubmed-author:BeguinYvesY,
pubmed-author:BronDominiqueD,
pubmed-author:CanonJean-LucJL,
pubmed-author:D'HondtLionelL,
pubmed-author:D'HondtVéroniqueV,
pubmed-author:FassotteMarie-FranceMF,
pubmed-author:FilletGeorgesG,
pubmed-author:HumbletYvesY,
pubmed-author:JerusalemGuyG,
pubmed-author:SymannMichelM,
pubmed-author:VermeulenPhilippeP
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
43
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
50-7
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:12519430-Adult,
pubmed-meshheading:12519430-Aged,
pubmed-meshheading:12519430-Antineoplastic Agents,
pubmed-meshheading:12519430-Breast Neoplasms,
pubmed-meshheading:12519430-Female,
pubmed-meshheading:12519430-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:12519430-Hematopoietic Stem Cell Mobilization,
pubmed-meshheading:12519430-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:12519430-Humans,
pubmed-meshheading:12519430-Leukapheresis,
pubmed-meshheading:12519430-Lymphoma,
pubmed-meshheading:12519430-Male,
pubmed-meshheading:12519430-Middle Aged,
pubmed-meshheading:12519430-Multiple Myeloma,
pubmed-meshheading:12519430-Recombinant Proteins,
pubmed-meshheading:12519430-Transplantation, Autologous
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Phase III randomized study comparing 5 or 10 microg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignancies.
|
|
pubmed:affiliation |
Groupe Oncologie UCL, Saint-Luc Academic Hospital, Brussels, Belgium. andre.marc@chndrf.be
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase III
|
